NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球抗生素市場研究報告:按藥物類別,按作用機理預測,到2025年-COVID-19的累積影響

Antibiotics Market Research Report by Action Mechanism, by Drug Class, by Spectrum, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989538
出版日期 內容資訊 英文 198 Pages
商品交期: 最快1-2個工作天內
價格
全球抗生素市場研究報告:按藥物類別,按作用機理預測,到2025年-COVID-19的累積影響 Antibiotics Market Research Report by Action Mechanism, by Drug Class, by Spectrum, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 198 Pages
簡介

2020年,全球抗生素市場規模為35189.41百萬美元/30,854.74百萬歐元。到2025年底,市場規模預計將達到47,974,290,000美元/42,041,090,000歐元。

COVID-19是前所未有的全球公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們解決潛在的COVID-19問題和未來路徑。該報告提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場趨勢以及政府的主要干預措施的變化。

該報告調查了抗生素市場,並提供了市場概況,以及按藥物類別,作用機理,區域,COVID-19的累積影響以及進入該市場的公司的概況的趨勢。

目錄

第1章簡介

  • 調查目的
  • 市場細分和範圍
  • 調查目標年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:調查計劃
    • 執行:調查實施
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • Outlook的類型
  • 按產品類型劃分的Outlook
  • 最終用途行業展望
  • 區域展望
  • 競爭對手的展望

第4章市場概述

  • 簡介
  • COVID-19的累積效果
  • 地域增長機會

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按藥物類別劃分的全球抗生素市場

  • 簡介
  • 氨基糖甘
  • 碳青黴烯
  • 頭孢菌素
  • 氟奎諾酮
  • 大環內酯
  • 青黴素
  • 磺□胺

第7章全球抗生素市場,通過作用機理

  • 簡介
  • 細胞壁合成抑製劑
  • DNA合成抑製劑
  • 黴菌酸抑製劑
  • 蛋白質合成抑製劑
  • RNA合成抑製劑

第8章美洲抗生素市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太抗生素市場

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東和非洲的抗生素市場

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第12章企業可用性簡介

  • Abbott Laboratories
  • Akron Incorporated
  • Amneal Pharmaceuticals LLC
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc
  • Bayer AG
  • Bristol Myers Squibb Company
  • Cadila Healthcare Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline PLC
  • Janssen Pharmaceuticals
  • Johnson & Johnson Services, Inc
  • KYORIN Holdings, Inc
  • LG Chem Ltd
  • Lupin Limited
  • Melinta Therapeutics, Inc
  • Merck & Co., Inc
  • MerLion Pharmaceuticals GmbH
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A
  • Shionogi & Company, Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd

第13章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-434CCDA05131

The Global Antibiotics Market size was estimated at USD 35,072.90 Million in 2020 and expected to reach USD 37,250.93 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.29% to reach USD 47,594.40 Million by 2025.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2025 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Action Mechanism, the Antibiotics Market was studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.

Based on Drug Class, the Antibiotics Market was studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.

Based on Spectrum, the Antibiotics Market was studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics.

Based on Geography, the Antibiotics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibiotics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibiotics Market, including Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Healthcare Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, KYORIN Holdings, Inc., LG Chem Ltd., Lupin Limited, Melinta Therapeutics, Inc., Merck & Co., Inc., MerLion Pharmaceuticals GmbH, Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., Shionogi & Co., Ltd., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Antibiotics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?
  • 6. What is the market share of the leading vendors in the Global Antibiotics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Antibiotics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Action Mechanism Outlook
  • 3.4. Drug Class Outlook
  • 3.5. Spectrum Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Patients Suffering from Infectious Diseases
      • 5.1.1.2. Development of Novel Strategies for New Antibiotics and a Large Number of Clinical Trials
      • 5.1.1.3. Extended Consumption in Low and Middle-Income Countries
    • 5.1.2. Restraints
      • 5.1.2.1. Misuse of Antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced Prospect Molecules and Novel Combination Therapies to Treat Antibiotic-Resistant Microbial Infections
      • 5.1.3.2. Growing in R&D and Investments for New Drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects Caused by the Usage of Antibiotic Drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Antibiotics Market, by Action Mechanism

  • 6.1. Introduction
  • 6.2. Cell Wall Synthesis Inhibitors
  • 6.3. DNA Synthesis Inhibitors
  • 6.4. Mycolic Acid Inhibitors
  • 6.5. Protein Synthesis Inhibitors
  • 6.6. RNA Synthesis Inhibitors

7. Antibiotics Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Aminoglycosides
  • 7.3. Carbapenem
  • 7.4. Cephalosporin
  • 7.5. Fluoroquinolone
  • 7.6. Macrolides
  • 7.7. Penicillin
  • 7.8. Sulfonamides

8. Antibiotics Market, by Spectrum

  • 8.1. Introduction
  • 8.2. Broad-spectrum Antibiotics
  • 8.3. Narrow-spectrum Antibiotics

9. Americas Antibiotics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antibiotics Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Antibiotics Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. Akron Incorporated
  • 13.3. Amneal Pharmaceuticals LLC
  • 13.4. Astellas Pharma, Inc.
  • 13.5. Bausch Health Companies, Inc.
  • 13.6. Bayer AG
  • 13.7. Bristol-Myers Squibb Company
  • 13.8. Cadila Healthcare Ltd.
  • 13.9. Eli Lilly and Company
  • 13.10. F. Hoffmann-La Roche AG
  • 13.11. Johnson & Johnson
  • 13.12. KYORIN Holdings, Inc.
  • 13.13. LG Chem Ltd.
  • 13.14. Lupin Limited
  • 13.15. Melinta Therapeutics, Inc.
  • 13.16. Merck & Co., Inc.
  • 13.17. MerLion Pharmaceuticals GmbH
  • 13.18. Mylan N.V.
  • 13.19. Novartis International AG
  • 13.20. Pfizer Inc.
  • 13.21. Sanofi S.A.
  • 13.22. Shionogi & Co., Ltd.
  • 13.23. Sun Pharmaceutical Industries Limited
  • 13.24. Teva Pharmaceutical Industries Ltd.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIBIOTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 2. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIBIOTICS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL ANTIBIOTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (%)
  • FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2025
  • FIGURE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, 2018-2025 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, 2018-2025 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, 2018-2025 (USD MILLION)
  • FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, 2018-2025 (USD MILLION)
  • FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, 2018-2025 (USD MILLION)
  • FIGURE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
  • FIGURE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025
  • FIGURE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2025 (USD MILLION)
  • FIGURE 25. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, 2018-2025 (USD MILLION)
  • FIGURE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, 2018-2025 (USD MILLION)
  • FIGURE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, 2018-2025 (USD MILLION)
  • FIGURE 31. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2025 (USD MILLION)
  • FIGURE 33. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, 2018-2025 (USD MILLION)
  • FIGURE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2025 (USD MILLION)
  • FIGURE 37. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 38. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2020 VS 2025 (%)
  • FIGURE 39. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2020 VS 2025 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2025
  • FIGURE 41. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, 2018-2025 (USD MILLION)
  • FIGURE 42. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 43. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, 2018-2025 (USD MILLION)
  • FIGURE 44. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 45. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 46. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 48. ARGENTINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. BRAZIL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. CANADA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. MEXICO ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. UNITED STATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 54. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 56. CHINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. INDIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. INDONESIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. JAPAN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. MALAYSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. THAILAND ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 65. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 67. FRANCE ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. GERMANY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. ITALY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. QATAR ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. RUSSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 74. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 75. SPAIN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 77. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 78. GLOBAL ANTIBIOTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 79. GLOBAL ANTIBIOTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIBIOTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANTIBIOTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. GLOBAL ANTIBIOTICS MARKET: SCORES
  • TABLE 105. GLOBAL ANTIBIOTICS MARKET: BUSINESS STRATEGY
  • TABLE 106. GLOBAL ANTIBIOTICS MARKET: PRODUCT SATISFACTION
  • TABLE 107. GLOBAL ANTIBIOTICS MARKET: RANKING
  • TABLE 108. GLOBAL ANTIBIOTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 109. GLOBAL ANTIBIOTICS MARKET: MERGER & ACQUISITION
  • TABLE 110. GLOBAL ANTIBIOTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 111. GLOBAL ANTIBIOTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 112. GLOBAL ANTIBIOTICS MARKET: INVESTMENT & FUNDING
  • TABLE 113. GLOBAL ANTIBIOTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 114. GLOBAL ANTIBIOTICS MARKET: LICENSE & PRICING
  • TABLE 115. GLOBAL ANTIBIOTICS MARKET: CONTACT DETAILS